baber/WOPTO huggingface dataset:
Patent AU-2019201885-A1 (AU)
Title: Client-side integration framework of services
Inventor: YAHALOM SAAR
IPC: H04L29/06
Filed: 2019-03-19
Abstract: A computer implemented method executing on a user's computing device comprising at least a processor and a memory, the method comprising: implementing on the processor of the user's computing device an integration framework stored in the memory on the user's computing device; receiving, at the integration framework, a request for a service from the user, the service corresponding to a service not implemented by the integration framework; accessing with the integration framework a registry of a plurality of services external to the integration framework, wherein each of the plurality of services of the registry is associated with a trust level of a hierarchy of trust levels; the integration framework identifying a subset of services of the plurality of services of the registry, wherein each service of the subset of services corresponds to the request for a service from the user, wherein providers of the plurality of providers associated with a most trusted trust level are providers available on the user's computing device, and providers of the plurality of providers associated with a second most trusted trust level are providers available on a sibling computing device; evaluating by the integration framework whether to obtain the service from a first provider of providers associated with a most trusted trust level or a second provider of providers associated with a second most trusted trust level according to one or more criteria; and determining, by the integration framework, to obtain the service from the second provider according to the one or more criteria and selecting the second provider as the found provider of the requested service; and issuing, by the user's computing device, an instruction from the integration framework to the found provider of the requested service to provide the requested service in response to the request. WO 2015/167940 PCT/US2015/027406 :Begin Receive request for service -1-502 Begin with local services (most trusted) 504 as current level 11Search current level for requested service 506 No :50 Service found on current level?50 Yes Issue instruction to provider for service J -,510 End Return indication of no service 514 No Another level to search? :: 512 Yes Next level is now current level 516
Patent AU-2019202356-A1 (AU)
Title: Systems, methods and devices for conducting transactions with electronic passbooks
Inventor: WHITE RICHARDSON CHARLES
IPC: G06Q20/02
Filed: 2019-04-04
Abstract: A method is disclosed for storing an electronic gift card (eGC) on a portable electronic device. The method includes: receiving a request for a web page hosted by a prepaid instrument provider server, the request including a uniform resource locator (URL) associated with a selected eGC stored on the server; associating with the selected eGC a unique identification code and a URL link to the selected eGC; sending the web page with a user interface control that, when selected, causes the selected eGC to be added to an electronic passbook on the portable electronic device; responsive to selection of the user-interface control, receiving the unique identification code associated with the selected eGC; responsive to receiving the unique identification code, creating an electronic passbook file for the selected eGC; and, communicating the electronic passbook file for adding as a representation of the selected eGC to the electronic passbook. WO 2014/042954 PCT/US2013/058272 U, c cjn c u a 0- U) U, C) 0 C")N co co "ft 0
Patent AU-2019202680-A1 (AU)
Title: Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
Inventor: ANDERSON ANNALIESA SYBIL
IPC: A61K39/09
Filed: 2019-04-17
Abstract: C:\Interwo n\NRPortbl\DCC\RBR\18700801-I.docx-10/04/2019 The invention relates to immunogenic polysaccharide-protein conjugates comprising a capsular polysaccharide (CP) from Streptococcus agalactiae, commonly referred to as group B streptococcus (GBS), and a carrier protein, 5 wherein the CP is selected from the group consisting of serotypes la, Ib, II, III, IV, V, VI, VII, VIII, and IX, and wherein the CP has a sialic acid level of greater than about 60%. The invention also relates to methods of making the conjugates and immunogenic compositions comprising the conjugates. The invention also relates to immunogenic compositions comprising polysaccharide-protein conjugates, 10 wherein the conjugates comprise a CP from GBS serotype IV and at least one additional serotype. The invention further relates to methods for inducing an immune response in subjects against GBS and/or for reducing or preventing invasive GBS disease in subjects using the compositions disclosed herein. The resulting antibodies can be used to treat or prevent GBS infection via passive 15 immunotherapy. WO 2016/178123 PCT/IB2016/052455 seraIgG sera IgG sera IgG sera IgG sera IgG sera IgG la lb 11 Ill IV V Serotype
Patent AU-2019204764-A1 (AU)
Title: Multi-instance architecture supporting trusted blockchain-based network
Inventor: SUBRAMANIAM SREENEVAS
IPC: H04L29/02
Filed: 2019-07-02
Abstract: An example embodiment performed by a scoped software application executable on a computing device of a computational instance within a trust group of computational instances of a remote network management platform may involve obtaining a representation of one or more transactions involving the computational instance. The embodiment may also involve encrypting the representation, using a pre-shared key to which at least some computational instances within the trust group have access. The embodiment may also involve placing the encrypted representation into a data block that also includes: (i) a first output generated by applying a hash function to content from a previous data block of a blockchain-based transaction ledger, and (ii) a second output generated by applying the hash function to the encrypted representation and the first output. The embodiment may also involve distributing copies of the data block to blockchain-based transaction ledgers within each computational instance of the trust group.
Patent AU-2019207134-A1 (AU)
Title: Timer processing method and terminal device
Inventor: KUANG YIRU
IPC: H04W52/02
Filed: 2019-01-11
Abstract: Provided in the present application are a timer processing method and a terminal device, the method comprising: a terminal device receives a first message sent by a network device and, on the basis of a scrambling identifier of the first message, starts or restarts a timer, the timer being a timer used by the terminal device for switching from an activated downlink BWP to a default downlink BWP or used by the terminal device for activating the default downlink BWP and deactivating the activated downlink BWP; if an activated BWP pair of the terminal device is not a default BWP pair, then the terminal device starts or restarts the timer on the basis of the scrambling identifier of the first message, the timer being a timer used by the terminal device for switching from an activated BWP pair to a default BWP pair or used by the terminal device for activating the default BWP pair and deactivating the activated BWP pair, thus solving the problem in the prior art of being unable to accurately switch to a default downlink BWP when starting or restarting a timer, and thereby reducing the power consumption of the terminal device.
Patent AU-2019226116-A1 (AU)
Title: Method and apparatus for patterned plasma-mediated laser trephination of the lens capsule and three dimensional phaco-segmentation
Inventor: ANDERSEN DAN E
IPC: A61B18/18
Filed: 2019-09-02
Abstract: Method and Apparatus for Patterned Plasma-Mediated Laser Trephination of the Lens Capsule and Three Dimensional Phaco-Segmentation A laser surgical system for making incisions in ocular tissue during a cataract surgical procedure, the system comprising: a laser operable to generate a laser beam for incising ocular tissue; a scanning assembly operable to direct a focal zone of the laser beam to locations within a patient's eye; an optical coherence tomography (OCT) imaging device; and a control 10 system operably coupled to the laser, the scanning assembly, and the OCT imaging device; the control system being configured to: operate the OCT imaging device to generate image data for ocular tissue of the patient, the image data including lens interior image data for an interior portion of the lens of the patient's eye; process the image data to determine an anterior capsulotomy scanning pattern for scanning the focal zone of the laser beam for performing an 15 anterior capsulotomy; and operate the laser and the scanning assembly to scan the focal zone of the laser beam in the anterior capsulotomy scanning pattern so as to perform the anterior capsulotomy, wherein positioning of the focal zone is guided by the control system based on the image data. 1flA7dfl(J
Patent AU-2019226280-A1 (AU)
Title: Helium extraction from natural gas
Inventor: WHITE VINCENT
IPC: F25J3/06
Filed: 2019-09-09
Abstract: A crude helium stream is recovered from a natural gas feed by distillation. Refrigeration from expanding a portion of the bottoms liquid is used to partially condense the helium enriched overhead vapor and generate a crude helium vapor and a helium-containing liquid stream that is recycled to the distillation column to maximize helium recovery. The helium-depleted natural gas stream can be returned at pressure for utilization or transportation. 101 ._____-- 1 5 1 6L -------------- 20 ------ 28 28' 3 1' 29 i R 2' Figure 2
Patent AU-2019229838-A1 (AU)
Title: Meat analogs comprising thin flakes for food compositions
Inventor: INGOGLIA CAROLINE
IPC: A23J3/04
Filed: 2019-03-06
Abstract: A method of making a food product includes forming an emulsion containing a meat and a firming agent that is one or more of plasma, whole egg powder, guar gum, pea fiber, pea protein, carboxymethyl cellulose (CMC) or a modified cereal starch; directing the emulsion through a die to form a meat analog; cooking the meat analog with steam; and cutting the meat analog into thin flakes. The method can include cooling the meat analog before the cutting. The method can include mixing the thin flakes of the meat analog with jelly or gravy to form a blended food composition in which a ratio of the flakes to the jelly or gravy is about 30:70 to about 70:30. The food product, which may be a pet food product, comprises a meat analog, which comprises thin flakes. The meat analog comprises meat (30 to 90 wt%) and a firming agent (6 to 9 wt%).
Patent AU-2019238994-A1 (AU)
Title: Electrostatic charge suppressor for persons
Inventor: FERNÁNDEZ DEL CASTILLO Y SIMÓN GUSTAVO
IPC: H05F3/02
Filed: 2019-02-14
Abstract: The invention relates to a suppressor device that neutralises the build-up of electrostatic charges in persons walking through places where the materials used to build them acquire an electrostatic charge, either due to their clothing or the type of flooring and footwear, generating electrostatic charges that build up to the point that a sudden discharge causes a spark that can be dangerous, especially in explosive atmospheres, harmful for electronic equipment and unpleasant for the person that feels them. The electrostatic charge suppressor uses a moderated electric discharge circuit and does so in a controlled time, while also switching on an LED or gas lamp (1) as a discharge indicator. The electrostatic charge suppressor is mounted on an insulating substrate (2) and is secured to a piece of furniture or a wall by adhesive or by a self-tapping screw, on a surface that has a certain level of conductivity to earth, placed at a point that it easily accessible for individuals walking through an area that is likely to generate an electrostatic charge in the persons walking through the place, who can touch the electrostatic discharge device as they pass through the place in order to get rid of the static electricity they built up.
Patent AU-2019246719-A1 (AU)
Title: A triple pharmaceutical combination comprising dabrafenib, trametinib and an Erk inhibitor
Inventor: MEYER MATTHEW JOHN
IPC: A61K31/4965
Filed: 2019-03-29
Abstract: The present invention relates to a pharmaceutical combination comprising dabrafenib, trametinib and an Erk-inhibitor; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions in the treatment or prevention of conditions in which MAPK pathway inhibition is beneficial, for example, in the treatment of cancers.
Patent AU-2019246947-A1 (AU)
Title: Systems and methods for refining estimated effects of parameters on amplitudes
Inventor: RAY ANANDAROOP
IPC: G06G7/48
Filed: 2019-03-27
Abstract: Systems and methods for refining estimated effects of parameters on amplitudes are disclosed. Exemplary implementations may: (a) obtain ranges of parameter values for individual parameters within a subsurface region of interest; (b) generate a first model of the subsurface region of interest; (c) calculate a synthetic seismogram from the first model to determine corresponding amplitudes; (d) store results of applying the synthetic seismogram; (e) repeat steps (b)-(d) for multiple additional models; (f) obtain a subsurface distribution; (g) apply the subsurface distribution to the multiple models and the corresponding amplitudes; (h) generate a representation; and (i) display the representation.
Patent AU-2019253774-A1 (AU)
Title: Improvements to truck bodies
Inventor: HALL JAMIE VINCENT CLARKE
IPC: B60P1/28
Filed: 2019-10-21
Abstract: of the Disclosure 
SYSTEM AND METHOD FOR CHANGING ORIENTATION OF MACHINES 
A method for changing an orientation of a machine at a worksite includes controlling, by a 
controller, a movement of the machine from a first position to a second position along a first 
route; controlling, by the controller, a movement of the machine from the second position 
to a third position along a second route; and controlling, by the controller, a movement of 
the machine from the third position towards the first position along a third route. Each of 
the first route, the second route, and the third route define respective apexes and combinedly 
define a region therebetween. One or more of the apexes are directed inwards into the 
region.
372 324 
14 48148 140 A
34384 *\,368 
334 
380 
340,344 
504 
136 500 
FIG. 6
Patent AU-2019269312-A1 (AU)
Title: Systems and methods for unifying statistical models for different data modalities
Inventor: ROTHBERG JONATHAN M
IPC: G06N3/04
Filed: 2019-05-08
Abstract: Techniques for performing a prediction task using a multi-modal statistical model configured to receive input data from multiple modalities including input data from a first modality and input data from a second modality different from the first modality. The techniques include: obtaining information specifying the multi-modal statistical model including values of parameters of each of multiple components of the multi-modal statistical model, the multiple components including first and second encoders for processing input data for the first and second modalities, respectively, first and second modality embeddings, a joint-modality representation, and a predictor; obtaining first input data for the first data modality; providing the first input data to the first encoder to generate a first feature vector; identifying a second feature vector using the joint-modality representation, the first modality embedding and the first feature vector; and generating a prediction for the prediction task using the predictor and the second feature vector.
Patent AU-2019269683-A1 (AU)
Title: In vivo blood filtration membranes and devices
Inventor: ROY SHUVO
IPC: B01D61/18
Filed: 2019-05-17
Abstract: Filtration membrane with improved mechanical stability and increased resistance to pressure is provided. The filtration membrane is useful for in vivo implantable filtration devices, such as, an artificial kidney. In vivo implantable filtration devices are also provided.
Patent AU-2019294492-A1 (AU)
Title: View-based breakpoints
Inventor: CASELLA TYLER L
IPC: G06F11/36
Filed: 2019-06-25
Abstract: Systems and methods for simulated reality view-based breakpoints are described. Some implementations may include accessing motion data captured using one or more motion sensors; determining, based at least on the motion data, a view within a simulated reality environment presented using a head-mounted display; detecting that the view is a member of a set of views associated with a breakpoint; based at least on the view being a member of the set of views, triggering the breakpoint; responsive to the breakpoint being triggered, performing a debug action associated with the breakpoint; and, while performing the debug action, continuing to execute a simulation process of the simulated reality environment to enable a state of at least one virtual object in the simulated reality environment to continue to evolve and be viewed with the head-mounted display.
Patent AU-2019302610-A1 (AU)
Title: Fused tri-cyclic compound as PDE3/PDE4 dual inhibitor
Inventor: LUO YUNFU
IPC: C07D471/04
Filed: 2019-07-12
Abstract: Provided is a fused tri-cyclic compound as PDE3/PDE4 dual inhibitor, and a use thereof in the preparation of drugs for PDE3/PDE4 associated diseases, particularly in medicinal functions such as chronic obstructive pulmonary disease (COPD). Provided are specifically a compound of formula (I) and a pharmaceutically acceptable salt thereof.
Patent AU-2019312838-A1 (AU)
Title: Aerosol generation
Inventor: AOUN WALID ABI
IPC: A24F40/20
Filed: 2019-07-31
Abstract: An aerosol generating article (101) for use in an aerosol generating assembly, the aerosol generating article comprising a rod (103) of aerosolisable material circumscribed by a wrapper, wherein the wrapper comprises an aerosol-forming amorphous solid.
Patent AU-2019331652-A1 (AU)
Title: Folate preparations
Inventor: ULMANN MARTIN
IPC: A61K31/519
Filed: 2019-08-29
Abstract: The present invention relates to preparations of folate for use in the treatment of eye disorders in the presence of elevated intraocular pressure.
Patent AU-2019365204-A1 (AU)
Title: Pharmaceutical compositions and methods of making on demand solid dosage formulations
Inventor: SINGH ONKAR N
IPC: A61K31/513
Filed: 2019-10-23
Abstract: A pharmaceutical composition and methods for using the pharmaceutical composition are disclosed. The pharmaceutical composition may include a therapeutically effective amount of one or more antiviral active pharmaceutical ingredients and a pharmaceutically acceptable excipient. The pharmaceutical composition may be a solid dosage form, wherein the solid dosage form provides sustained release of the antiviral active pharmaceutical ingredient when administered as a vaginal or rectal insert.
Patent AU-2019370735-A1 (AU)
Title: Novel urea 6,7-dihydro-4H-pyrazolo(1,5-a)pyrazines active against the hepatitis B virus (HBV)
Inventor: DONALD ALASTAIR
IPC: A61P31/12
Filed: 2019-11-01
Abstract: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
Patent AU-2019374981-A1 (AU)
Title: Peptide fragments for treatment of diabetes
Inventor: ALENFALL JAN
IPC: A61K38/00
Filed: 2019-11-07
Abstract: The present disclosure concerns agents and their use in the treatment of endocrine, nutritional and/or metabolic diseases in a mammal. The disclosure furthermore concerns novel peptide fragments.
Patent AU-2019384157-A1 (AU)
Title: Gaboxadol for reducing risk of suicide and rapid relief of depression
Inventor: OSTEN PAVEL
IPC: A61B5/374
Filed: 2019-11-21
Abstract: Methods and compositions are disclosed for rapidly reducing the risk of suicide in patients suffering from acute suieidality and rapidly relieving mood symptoms in major depression and treatment-resistant depression using a novel therapeutic regimen comprising a single or intermittent administration of a high dose of gaboxadol, or a pharmaceutically acceptable salt thereof, to the subject in need thereof.
Patent AU-2019387491-A1 (AU)
Title: Expansion of natural killer cells and ILC3 cells with novel aromatic compounds
Inventor: HARIRI ROBERT J
IPC: C12N5/0783
Filed: 2019-11-29
Abstract: Provided herein are methods of producing natural killer (NK) cells and/or ILC3 cells using a three-stage expansion and differentiation method with media comprising stem cell mobilizing factors. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein to an individual having the cancer or viral infection.
Patent AU-2019391925-A1 (AU)
Title: Double-glass photovoltaic assembly
Inventor: CHEN DAOYUAN
IPC: H01L31/048
Filed: 2019-06-28
Abstract: The present disclosure belongs to the technical field of photovoltaics, and relates to a double-glass photovoltaic assembly. The double-glass photovoltaic assembly comprises a laminate member, a junction box, and a first frame and a second frame disposed only at two long sides of the laminate member. The laminate member comprises a cover plate glass, a first encapsulation adhesive film, a battery string, a second encapsulation adhesive film, a back plate glass, and a busbar. A through-hole is provided at the back plate glass. An end of the busbar is connected to the battery string. Another end of the busbar passes through the through-hole, and is bent to form a bent edge to be connected to the junction box. The bent edge of the busbar does not contact an edge of the through-hole. The double-glass photovoltaic assembly adopting a double-frame design can meet the requirements of load capacity. Moreover, since the assembly, after being fitted to a photovoltaic power generation system, does not have a frame disposed at a lower side to prevent light from entering a back surface of the assembly from the ground, power generation at the back surface of the double-glass photovoltaic assembly would not be affected, and dust and snow do not easily accumulate on the assembly. The double-glass photovoltaic assembly also has a reduced weight and lowered costs.
Patent AU-2019393950-A1 (AU)
Title: Herbicide compositions
Inventor: TRABOLD KLAUS
IPC: A01P13/00
Filed: 2019-12-02
Abstract: The present invention relates to compositions containing herbicidally effective compounds (A) and (B), where (A) stands for one or more compounds of general formula (I) or the agrochemically compatible salts thereof [component (A)], (I) and (B) stands for one or more herbicides [component (B)]. The application further relates to a method and to the use of the herbicidal composition according to the invention to combat weeds or regulate growth..
Patent AU-2019412713-A1 (AU)
Title: Method for adjusting a cell concentration and/or a particle concentration in a dispensing system
Inventor: SCHÖNDUBE JONAS
IPC: C12M1/00
Filed: 2019-12-12
Abstract: The invention relates to a method for adjusting a cell concentration and/or a particle concentration in a dispensing system, using which a liquid sample can be dispensed, in which method the cell concentration and/or particle concentration in one region of the dispensing system is determined, said determined cell concentration and/or particle concentration is compared to a reference value, and depending on the result of this comparison, a force exerted on a cell and/or on a particle is adjusted.